ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020 | -25.7% | 212,500 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $1,373 | +139.6% | 182,800 | +44.1% | 0.00% | +100.0% |
| Q1 2023 | $573 | -46.9% | 126,819 | +32.4% | 0.00% | 0.0% |
| Q4 2022 | $1,080 | -99.9% | 95,800 | -43.8% | 0.00% | -50.0% |
| Q3 2022 | $1,633,000 | -11.3% | 170,600 | -25.1% | 0.00% | 0.0% |
| Q2 2022 | $1,842,000 | -26.8% | 227,683 | +53.0% | 0.00% | -33.3% |
| Q1 2022 | $2,515,000 | -30.3% | 148,800 | -11.4% | 0.00% | -25.0% |
| Q4 2021 | $3,608,000 | – | 167,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $109,318,155 | 33.89% |
| Vivo Capital, LLC | 4,220,048 | $47,560 | 5.48% |
| Logos Global Management LP | 2,349,600 | $26,479,992 | 3.10% |
| Samsara BioCapital, LLC | 262,786 | $2,961,598 | 0.64% |
| Orbimed Advisors | 2,871,000 | $32,356,170 | 0.62% |
| Pier Capital, LLC | 271,848 | $3,063,727 | 0.50% |
| Cormorant Asset Management, LP | 612,079 | $6,898 | 0.46% |
| Nan Fung Group Holdings Ltd | 41,950 | $472,777 | 0.33% |
| Artal Group S.A. | 500,000 | $5,635 | 0.32% |
| Redmile Group, LLC | 607,470 | $6,846,187 | 0.28% |